Daniel J. O'Connor
2020 - OncoSec Medical
In 2020, Daniel J. O'Connor earned a total compensation of $1.4M as President and Chief Executive Officer at OncoSec Medical, a 15% increase compared to previous year.
Compensation breakdown
| Bonus | $326,993 |
|---|---|
| Option Awards | $502,086 |
| Salary | $513,462 |
| Other | $10,645 |
| Total | $1,353,186 |
O'Connor received $513.5K in salary, accounting for 38% of the total pay in 2020.
O'Connor also received $327K in bonus, $502.1K in option awards and $10.6K in other compensation.
Rankings
In 2020, Daniel J. O'Connor's compensation ranked 7,303rd out of 13,090 executives tracked by ExecPay. In other words, O'Connor earned more than 44.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,303 out of 13,090 | 44th |
Division Manufacturing | 3,057 out of 5,624 | 46th |
Major group Chemicals And Allied Products | 1,231 out of 2,257 | 46th |
Industry group Drugs | 1,064 out of 1,957 | 46th |
Industry Pharmaceutical Preparations | 797 out of 1,462 | 46th |
Source: SEC filing on March 18, 2021.
O'Connor's colleagues
We found two more compensation records of executives who worked with Daniel J. O'Connor at OncoSec Medical in 2020.
News
OncoSec Medical CEO Daniel O'Connor's 2021 pay jumps 122% to $3M
May 31, 2022
OncoSec Medical CEO Daniel O'Connor's 2020 pay rises 15% to $1.4M
March 18, 2021
OncoSec Medical CEO Daniel O'Connor's 2019 pay falls 72% to $1.2M
April 30, 2020
OncoSec Medical CEO Daniel O'Connor's 2018 pay falls 39% to $4.2M
November 8, 2018